AbbVie Inc. (ABBV) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - General industria. La empresa tiene su sede en North Chicago, IL, United States. El CEO actual es Scott T. Reents.
ABBV tiene fecha de IPO 2013-01-02, 55,000 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $372.01B.
AbbVie Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a diverse portfolio of medicines across multiple therapeutic areas. The company's key products include HUMIRA for autoimmune diseases, SKYRIZI for psoriasis, RINVOQ for rheumatoid arthritis, IMBRUVICA and VENCLEXTA for blood cancers, and MAVYRET for hepatitis C, along with established brands such as Synthroid for hypothyroidism, Botox, Lupron, and Linzess for gastrointestinal conditions. AbbVie also offers specialized treatments in ophthalmology, neurology, and women's health, including eye care solutions and migraine therapies. Headquartered in North Chicago, Illinois, and incorporated in 2012, the company maintains research collaborations to advance its drug pipeline and expand its global reach.
